BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

GenVault Corporation Receives Four Critical U.S. and E.U. Patent Allowances for Key Biosample Management Technologies


5/20/2009 10:34:23 AM

CARLSBAD, Calif., May 20 /PRNewswire/ -- GenVault Corporation is pleased to announce notice of allowance for four key patents in its growing portfolio. U.S. Patent Application #10/005,415, entitled "Automated Biological Sample Archive for Storage, Retrieval & Analysis of a Large Number of Samples" and European Patent Application #02776478.6, entitled "Archive & Analysis System and Method," complement the already-awarded U.S. patent U.S. Patent #7,142,987. Taken together, these allowed and awarded patents grant GenVault broad, exclusive, intellectual property coverage in support of its core business: the development and commercialization of consumables, hardware and software for the acquisition, storage and recovery of biological specimens that have been preserved in the dried solid state, to be used for the building and use as biobanks or biorepositories.

GenVault is also pleased to announce notice of allowance of the first of several key patents in its portfolio which cover novel matrices to stabilize biospecimens in the air-dried state. The allowed claims in "Stable Protein Storage and Stable Nucleic Acid Storage in Recoverable Form," U.S. Patent Application #11/137,806 and European Patent Application #05754240.9, grant GenVault broad, exclusive intellectual property coverage in support of a range of new products based on biospecimen stabilization in engineered sponge and similar materials. The company feels that this new "elastomeric" matrix offers the promise to be a replacement for filter paper, swabs and a number of other matrices for the collection, shipping and storage of biospecimens, especially in the context of public health and personalized medicine.

"GenVault continues to strengthen its leadership position in the emerging field of efficient and cost effective biosample management with an expanding patent portfolio," said David Wellis, CEO, GenVault. "Our growth and value strategy includes firmly establishing GenVault's intellectual property position which enables the company to exclusively market consumables, hardware and software solutions for the efficient transport and banking of biosamples."

About GenVault

GenVault is the global leader in providing risk free biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable, reliable and environmentally friendly alternative to traditional freezers and DNA purification systems, the company's dry-state platforms enable the extraction, preservation, recovery, and distribution of DNA at ambient temperatures. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at www.genvault.com.

Available Topic Expert(s): For information on the listed expert(s), click

appropriate link.

Bret Dash

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87941

CONTACT: Bret Dash, Director of Marketing of GenVault Corporation,
+1-760-268-5242, bdash@genvault.com

Web site: http://www.genvault.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->